Barhemsys

Indicated For

postoperative nausea and vomiting, PONV

About This Medication

# Acacia Pharma Patient Assistance Program for Barhemsys (amisulpride): How to Get Help Paying for Your Medication Barhemsys (amisulpride) is an FDA-approved intravenous medication used to prevent and treat postoperative nausea and vomiting (PONV) in adults. While Acacia Pharma, the manufacturer, does not appear to offer a publicly detailed patient assistance program based on available information, this guide outlines general steps for seeking financial help, eligibility considerations, and alternatives to access **Barhemsys** at low or no cost.[1][2] ## About Barhemsys and Why You Might Need Assistance **Barhemsys** is a selective dopamine-2 (D2) and dopamine-3 (D3) receptor antagonist—the first and only FDA-approved antiemetic specifically for rescue treatment of breakthrough PONV after failed prophylaxis with a different class of antiemetic.[1] It's administered as a single IV dose of 5 mg or 10 mg over 1-2 minutes in hospital settings for: - Prevention of PONV, alone or combined with another antiemetic class. - Treatment of PONV in patients who received prophylaxis with a different agent or none at all.[1][2][3] Clinical trials showed **Barhemsys 10 mg** reduced PONV effectively, shortened mean PACU length of stay by 35 minutes, and hospital stay by 6 hours compared to placebo.[1] It's nonsedating and given only in acute care settings like hospitals due to QT prolongation risks—ECG monitoring is recommended.[2][3] As a hospital-administered drug with Medicare pass-through status (ASP + 6% reimbursement), costs can be high for uninsured or underinsured patients. Without a dedicated program listed on Acacia Pharma's sites, patients often qualify for free meds through general assistance foundations or hospital billing support.[1][8] ## Who Qualifies for Assistance? Specific income thresholds for an Acacia Pharma program are not publicly available—no dedicated patient assistance program (PAP) details appear on Barhemsys.com or Acacia Pharma resources.[1][2][7] Generally, pharmaceutical PAPs target: - Uninsured or underinsured U.S. residents. - Household income at or below **400-500% of the Federal Poverty Level (FPL)** (varies by program). | Household Size | 400% FPL (2026 est.) | 500% FPL (2026 est.) | |---------------|----------------------|----------------------| | 1 person | ~$60,320 | ~$75,400 | | 2 people | ~$81,760 | ~$102,200 | | 3 people | ~$103,280 | ~$129,000 | | 4 people | ~$124,800 | ~$155,800 | *Notes: Figures are estimates based on standard FPL adjustments; actual eligibility depends on the assisting program. Add ~$21,440 per person for larger families at 400% FPL. Medicare patients often ineligible for PAPs but may use Extra Help.*[5][6] ## Insurance Requirements Most PAPs require commercial insurance but exclude Medicare, Medicaid, or VA patients—check specifics.[5][6][8] **Barhemsys** has HCPCS code J0184 (amisulpride, 1 mg) with Medicare pass-through status through ~2026, potentially covering costs in ASCs/HOPDs.[8] If insured, explore copay assistance; uninsured patients turn to PAP alternatives below.[1][8] ## Step-by-Step Application Process 1. **Contact Acacia Pharma Directly**: Call **1-877-357-9237** (adverse events line, but inquire about assistance).[2] Ask for PAP details, as none are listed online. 2. **Use General PAP Databases**: - Visit **NeedyMeds.org** or **RxAssist.org**; search "amisulpride" or "Barhemsys." - Check **Partnership for Prescription Assistance (PPAR.org)** for matching.[5][6] 3. **Apply to Independent Foundations**: - **Patient Access Network (PAN) Foundation**: For underinsured with copays >$500/year. - **HealthWell Foundation**: Covers PONV meds for uninsured/underinsured. - **Patient Advocate Foundation Co-Pay Relief**: Surgery-related costs. Submit online apps with proof of income, prescription, and denial letters.[5] 4. **Hospital Financial Aid**: Request charity care or indigent programs—**Barhemsys** is office/hospital-administered.[3] 5. **Gather Documents**: Proof of residency, income (tax returns/W-2s), prescription, insurance denial (if applicable).[5][6] ## Timeline and Delivery Processing typically takes **2-4 weeks** for PAPs; hospital delivery is immediate post-approval since it's IV.[5] Expect medication shipped to your healthcare provider, not home. Track via program portals.[1][3] ## Alternatives if Denied or No Program Exists - **Generic/Biosimilars**: None available for amisulpride.[1] - **Other Antiemetics**: Ondansetron (Zofran), granisetron, or aprepitant—discuss with doctor.[1] - **Manufacturer Samples**: Request via prescriber.[1] - **State Programs**: Check state pharmaceutical aid. - **Clinical Trials**: Search ClinicalTrials.gov for PONV studies. ## Disclaimer This guide uses publicly available data as of 2026; no specific Acacia Pharma PAP confirmed.[1][2] Eligibility varies—consult healthcare provider or programs directly. Not medical/financial advice. Report side effects to Acacia at 1-877-357-9237 or FDA at 1-800-FDA-1088.[2] Always verify current details.

Program information last verified: March 30, 2026